“multiple-sclerosis” Archives

in
Entry Author Date Location
Arbor Pharma Pays $467M for Struggling XenoPort, Restless Legs Drug 05/23/16 San Francisco
Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance 05/16/16 Boston
Biogen’s Scangos on Pricing, Deals, Hemophilia, Alzheimer’s & More 02/09/16 Boston
Biogen, Arsia Team Up to Improve Hemophilia Drugs in $100M Pact 12/16/15 Boston
In New York and Montreal, Versant Seeds Two New Biotech Startups 12/10/15 New York
NY Stem Cell Foundation Grows, Eyes Forming Big Apple Bio Incubator 12/03/15 New York
Biogen to Cut 400 Jobs in Massachusetts in Big Restructuring 10/21/15 Boston
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
Biogen Pays $60M to Take on Celgene With a Rival Autoimmune Drug 09/09/15 Boston
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
RayVio Absorbs $9.3M for UV Technology to Clean Water and Air 03/10/15 San Francisco
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
Roundup: UT’s Food Lab, Houston Angel Network, SecureNok, & More 02/18/15 Texas
East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More 02/13/15 Boston
Fannin Spinout Acelerox Aims to Halt Immune Attacks With Nanotech 02/11/15 Texas
With Early Data, Alkermes Plots Quick Jump to Pivotal Study For MS Drug 02/09/15 Boston
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
West Coast Biotech Roundup: Qualcomm, Google X, Mapp, Onyx, & More 01/29/15 San Francisco
Investors Line up For Westphal as Muscle Cramp Startup Upsizes IPO 01/28/15 Boston
Speaking LINGO, Biogen R&D Chief Wants to Push Nerve Repair Boundary 01/26/15 Boston
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
Deltanoid and Beyond: Madison Legend DeLuca Has More “D” To Play 11/17/14 Wisconsin
Alkermes Spinoff Civitas, Poised for IPO, Sells to Acorda for $525M 09/24/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
Page 1 of 8 next page »